4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow Prostate Cancer Recurrent: new trials by email Literature Review of Prostate Cancer Recurrent trials Research Report on Prostate Cancer Recurrent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer [18F]PSMA-1007 - Prostate Cancer, Prostate Cancer Recurrent | Phase 3 | Completed | ABX advanced biochemical compounds GmbH | 136 | 2021-08-27 | 2025-07-15 |
| Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer. [18F] PSMA-1007 Injection - Prostate Cancer Recurrent, Recurrent Prostate Cancer | Phase 3 | Completed | Centre for Probe Development and Commercialization | 100 | 2020-12-21 | 2024-02-07 |
| F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence F-18-PSMA-1007, F-18-Fluorocholine - Prostate Cancer, Prostate Cancer Recurrent | Phase 3 | Completed | ABX advanced biochemical compounds GmbH | 200 | 2019-03-06 | 2021-06-29 |
| Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer 18F-DCFPyL, PET/CT Imaging - Prostate Cancer, Prostate Adenocarcinoma | Phase 3 | Completed | Progenics Pharmaceuticals, Inc. | 208 | 2018-11-27 | 2021-06-14 |
Prostatic Neoplasms (4) · Disease (1)
Genital Diseases (4) · Genital Diseases, Male (4) · Genital Neoplasms, Male (4) · Male Urogenital Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Prostatic Diseases (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid (1)
ABX advanced biochemical compounds GmbH (2) · Centre for Probe Development and Commercialization (1) · Progenics Pharmaceuticals, Inc. (1)
Canada (2) · United States (2) · France (1) · Netherlands (1) · Switzerland (1)
Jessica D Jensen (1)